Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 121, Issue 3, Pages 1163-1173
Publisher
American Society for Clinical Investigation
Online
2011-02-17
DOI
10.1172/jci41651
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evidence That Niacin Inhibits Acute Vascular Inflammation and Improves Endothelial Dysfunction Independent of Changes in Plasma Lipids
- (2010) Ben J. Wu et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Nicotinic acid– and monomethyl fumarate–induced flushing involves GPR109A expressed by keratinocytes and COX-2–dependent prostanoid formation in mice
- (2010) Julien Hanson et al. JOURNAL OF CLINICAL INVESTIGATION
- CXC Chemokine Ligand 4 Induces a Unique Transcriptome in Monocyte-Derived Macrophages
- (2010) C. A. Gleissner et al. JOURNAL OF IMMUNOLOGY
- The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6–HDL and LDL Treatment Strategies in Atherosclerosis)
- (2010) Todd C. Villines et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Niacin stimulates adiponectin secretion through the GPR109A receptor
- (2009) Eric P. Plaisance et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Macrophage Diversity and Polarization in Atherosclerosis
- (2009) Alberto Mantovani et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Role of HDL, ABCA1, and ABCG1 Transporters in Cholesterol Efflux and Immune Responses
- (2009) Laurent Yvan-Charvet et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Anti-inflammatory effects of nicotinic acid in adipocytes demonstrated by suppression of fractalkine, RANTES, and MCP-1 and upregulation of adiponectin
- (2009) Janet E. Digby et al. ATHEROSCLEROSIS
- Effects of Niacin on Cell Adhesion and Early Atherogenesis: Biochemical and Functional Findings in Endothelial Cells
- (2009) Subramaniam Tavintharan et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Nicotinic acid: A new look at an old drug
- (2009) John A. Farmer Current Atherosclerosis Reports
- Nicotinic acid and the prevention of coronary artery disease
- (2009) Janet E Digby et al. CURRENT OPINION IN LIPIDOLOGY
- β-Arrestin1 mediates nicotinic acid–induced flushing, but not its antilipolytic effect, in mice
- (2009) Robert W. Walters et al. JOURNAL OF CLINICAL INVESTIGATION
- LXR and ABCA1 control cholesterol homeostasis in the proximal mouse epididymis in a cell-specific manner
- (2009) Aurélia Ouvrier et al. JOURNAL OF LIPID RESEARCH
- Effects of High-Dose Modified-Release Nicotinic Acid on Atherosclerosis and Vascular Function
- (2009) Justin M.S. Lee et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Update on strategies to increase HDL quantity and function
- (2009) Danielle Duffy et al. Nature Reviews Cardiology
- Mechanism of Action of Niacin
- (2008) Vaijinath S. Kamanna et al. AMERICAN JOURNAL OF CARDIOLOGY
- CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways
- (2008) Fabrizio Montecucco et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Is high HDL cholesterol always good?
- (2008) Anders G. Olsson ANNALS OF MEDICINE
- Extended-Release Niacin Alters the Metabolism of Plasma Apolipoprotein (Apo) A-I and ApoB-Containing Lipoproteins
- (2008) Stefania Lamon-Fava et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Niacin Increases HDL by Reducing Hepatic Expression and Plasma Levels of Cholesteryl Ester Transfer Protein in APOE*3Leiden.CETP Mice
- (2008) José W.A. van der Hoorn et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Rimonabant, a Selective Cannabinoid CB1 Receptor Antagonist, Inhibits Atherosclerosis in LDL Receptor–Deficient Mice
- (2008) Frédérique Dol-Gleizes et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Niacin inhibits vascular oxidative stress, redox-sensitive genes, and monocyte adhesion to human aortic endothelial cells
- (2008) Shobha H. Ganji et al. ATHEROSCLEROSIS
- The psoriasis drug monomethylfumarate is a potent nicotinic acid receptor agonist
- (2008) Hua Tang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Endothelial Cell-Specific NF-κB Inhibition Protects Mice from Atherosclerosis
- (2008) Ralph Gareus et al. Cell Metabolism
- RhoA/ROCK I signalling downstream of the P2Y13 ADP-receptor controls HDL endocytosis in human hepatocytes
- (2008) C MALAVAL et al. CELLULAR SIGNALLING
- Niacin: An old drug rejuvenated
- (2008) Vaijinath S. Kamanna et al. Current Atherosclerosis Reports
- 3-(1H-Tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): A Partial Agonist of the Nicotinic Acid Receptor, G-Protein Coupled Receptor 109a, with Antilipolytic but No Vasodilatory Activity in Mice
- (2008) Graeme Semple et al. JOURNAL OF MEDICINAL CHEMISTRY
- Is raising HDL a futile strategy for atheroprotection?
- (2008) Tisha Joy et al. NATURE REVIEWS DRUG DISCOVERY
- Spotlight on HDL-raising therapies: insights from the torcetrapib trials
- (2008) Anatol Kontush et al. Nature clinical practice. Cardiovascular medicine
- Management of Lipids in the Prevention of Cardiovascular Events
- (2007) Helene Glassberg et al. Annual Review of Medicine
- Nicotinic Acid: Pharmacological Effects and Mechanisms of Action
- (2007) Andreas Gille et al. Annual Review of Pharmacology and Toxicology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started